Related Experiment Video
Updated: May 23, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Cancer overdiagnosis and overtreatment
1Division of Urology, University of Toronto, Toranto, Ontario, Canada. Laurence.klotz@sunnybrook.ca
Current Opinion in Urology
|April 5, 2012
Summary
Cancer screening advances early detection, leading to overdiagnosis of indolent cancers. Reducing overtreatment is key to successful cancer screening programs.
Area of Science:
- Oncology
- Medical Diagnostics
- Public Health
Background:
- Cancer diagnosis has shifted from late-stage to include early-stage and indolent disease due to earlier detection methods.
- Screening programs have increased the identification of clinically insignificant cancers, alongside improved outcomes for aggressive cancers detected earlier.
- Overdiagnosis occurs when screening tests identify microfocal disease, particularly in breast, prostate, and thyroid cancers.
Purpose of the Study:
- To summarize the significant problem of cancer overdiagnosis and overtreatment in modern medicine.
- To highlight the complexities and trade-offs associated with cancer overdiagnosis.
- To underscore the importance of addressing overdiagnosis in various cancer types, especially prostate cancer.
Main Methods:
- Review of current medical literature and screening program outcomes.
- Analysis of the impact of early detection on cancer heterogeneity.
- Examination of the relationship between screening, overdiagnosis, and overtreatment.
Main Results:
- Screening has led to a rise in the diagnosis of indolent (slow-growing) cancers.
- While screening improves survival for aggressive cancers, it also increases the detection of non-life-threatening conditions.
- Prostate cancer screening demonstrates a significant reduction in mortality, but overdiagnosis remains a major concern.
Conclusions:
- Addressing overtreatment of indolent cancers is crucial for the overall success and integrity of cancer screening initiatives.
- The complexity of cancer overdiagnosis necessitates careful consideration of benefits and harms.
- Effective management strategies are needed to mitigate the negative impacts of overdiagnosis in cancer screening.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
02:12What is Cancer?
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...